PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.53%
Revenue growth above 1.5x 3391.T's 0.13%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
4.70%
Gross profit growth above 1.5x 3391.T's 0.64%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
33.61%
EBIT growth 50-75% of 3391.T's 48.71%. Martin Whitman would suspect suboptimal resource allocation.
19.88%
Operating income growth under 50% of 3391.T's 48.71%. Michael Burry would be concerned about deeper cost or sales issues.
11.98%
Net income growth under 50% of 3391.T's 102.20%. Michael Burry would suspect the firm is falling well behind a key competitor.
11.99%
EPS growth under 50% of 3391.T's 102.36%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
11.99%
Diluted EPS growth under 50% of 3391.T's 102.21%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 3391.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.01%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.19%
10Y revenue/share CAGR under 50% of 3391.T's 180.40%. Michael Burry would suspect a lasting competitive disadvantage.
49.64%
5Y revenue/share CAGR at 75-90% of 3391.T's 57.67%. Bill Ackman would encourage strategies to match competitor’s pace.
23.37%
3Y revenue/share CAGR similar to 3391.T's 22.62%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.11%
Below 50% of 3391.T's 113.73%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
35.31%
5Y net income/share CAGR above 1.5x 3391.T's 14.32%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
27.80%
3Y net income/share CAGR above 1.5x 3391.T's 3.68%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
180.29%
10Y equity/share CAGR at 75-90% of 3391.T's 208.37%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
118.59%
5Y equity/share CAGR above 1.5x 3391.T's 64.34%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
55.15%
3Y equity/share CAGR above 1.5x 3391.T's 30.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.00%
Firm’s AR is declining while 3391.T shows 4.83%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-0.48%
Inventory is declining while 3391.T stands at 0.03%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.68%
Asset growth above 1.5x 3391.T's 0.30%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.68%
BV/share growth above 1.5x 3391.T's 1.37%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-50.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.98%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.